Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Coronary Flow Reserve in Patients with Intermediate FFR: Should We Use This Tool to Define When to Perform Coronary Angioplasty?

Current guidelines recommend using fractional flow reserve (FFR) to guide coronary angioplasty. However, intermediate FFR values (0.75-0.80) generate uncertainty about the prognostic value of performing coronary angioplasty over optimal medical treatment.

reserva fraccional de flujo sindrome coronario agudo

The use of coronary flow reserve (CFR) together with FFR provides further insight into coronary circulation because CFR is an index that also includes microcirculation assessment.

The aim of this retrospective study was to evaluate the prognosis between deferring vs. performing coronary angioplasty according to CFR score in patients with intermediate FFR.

The endpoint was treated vessel failure (TVF), defined as a composite of cardiovascular death, treated-vessel-related infarction, and clinically driven repeat vascularization of the treated vessel.

Out of the 2322 patients in the ILIAS Registry (Inclusive Invasive Physiological Assessment in Angina Syndromes Registry), 400 had intermediate FFR stenosis and were included in this study. Coronary angioplasty was differed in 210 patients (deferred group) and it was performed in 190 patients (performed group). They were further stratified according to CFR value into preserved CFR (>2) and decreased CFR (≤2).

Mean patient age was 60 years old. The most frequent clinical presentation was unstable angina. The most frequently treated artery was the anterior descending artery. According to CRF, angioplasty was performed in 38% of the preserved CFR cohort, and in 61% of the decreased CRF cohort.

Read also: Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus after ST-Segment Elevation Acute Coronary Syndrome.

There were no significant differences in TVF between groups at 5 years of follow-up. However, when performed in decreased CRF patients, the risk of TVF was higher for the deferred group when compared with the performed group (17.2% vs. 14.2%, hazard ratio: 4.932; 95% confidence interval: 1.312 to 18.53; p = 0.018). This difference was at the expense of a higher rate of revascularization of the treated vessel (12.1% vs. 8.3%; p = 0.025).

Conclusion

In patients with an intermediate FFR of 0.75-0.80, the prognostic value of the therapeutic strategy differed according to CFR value. Coronary angioplasty was associated with a lower rate of TVF when the CFR was decreased. However, there were no differences in TVF in patients with preserved CFR.

CFR can be used to stratify risk in patients with intermediate FFR to determine therapeutic strategy.

Dr. Andrés Rodríguez
Member of the Editorial Board of SOLACI.org .

Original Title: Differential Prognostic Value of Revascularization for Coronary Stenosis With Intermediate FFR by Coronary Flow Reserve.

Reference: Juwon Kim, MD et al J Am Coll Cardiol Intv 2022.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...

Calcified Nodules and Their Treatment with Rotational Atherectomy

Calcified nodules (CN) represent one of the most complex phenotypes to treat in coronary intervention. They are mainly associated with the need for repeat...

Complex PCI: higher ischemic and bleeding risk in contemporary practice

Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in a growing number of patients with a...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...